KXA
TMDX icon

KPCB XIII Associates’s Transmedics TMDX Stock Holding History

KPCB XIII Associates’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$30.5M Hold
923,221
– – 6.09% 3
2021
Q2 		$30.6M Hold
923,221
– – 5.64% 4
2021
Q1 		$38.3M Sell
923,221
-9,000
-1% -$277K 7.87% 3
2020
Q4 		$18.4M Buy
+932,221
New +$13.8M 2.97% 4

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KPCB XIII Associates's TMDX Position: Q3 2021 in Review

KPCB XIII Associates held its Transmedics (TMDX) position steady in Q3 2021 at 923,221 shares worth $30.5M. The position accounts for 6.09% of the portfolio, ranked #3.

KPCB XIII Associates first reported a position in TMDX in Q4 2020 and has held it in 4 quarters since. The position peaked at $38.3M in Q1 2021. 120 funds tracked by Wall St. Rank hold TMDX as of Q3 2021.

  • KPCB XIII Associates held 923,221 shares of Transmedics worth $30.5M as of Q3 2021.
  • KPCB XIII Associates left its Transmedics share count unchanged in Q3 2021.
  • Transmedics made up 6.09% of KPCB XIII Associates's portfolio in Q3 2021, its #3 holding.
  • KPCB XIII Associates first reported a position in Transmedics in Q4 2020 and has held it in 4 quarters since.
  • KPCB XIII Associates's Transmedics position peaked at $38.3M in Q1 2021.
  • 120 funds tracked by Wall St. Rank held Transmedics as of Q3 2021.

Based on KPCB XIII Associates's 13F filing for Q3 2021, filed 25 Oct 2021.